naltrexone (REVIA, TREXAN, VIVITROL)

Update on Buprenorphine for the Treatment of Opioid-Use Disorder
July 2023
Treatment of opioid-use disorder is an important part of the public health response to the opioid epidemic in the United States. Learn about recent research that continues to support the effectiveness and safety of buprenorphine as a treatment for opioid-use disorder.

Beware of Companies Peddling Illegal Opioid Addiction Remedies
April 2018
In his editor’s column, Dr. Michael Carome offers advice on how to avoid being conned by unscrupulous companies promising miracle treatments for opioid addiction and withdrawal.

Naltrexone-Bupropion (CONTRAVE): Another Dangerous Weight-Loss Drug
September 2017
Learn why Public Citizen’s Health Research Group has designated CONTRAVE, a combination weight-loss medication that was approved by the FDA in 2014, as Do Not Use.